Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 4Wound Infection 2Infections 2Surgical Wound Infection 1Prostatic Neoplasms 1Laryngeal Neoplasms 1Clinical Stage I Cutaneous Melanoma AJCC v8 1Carcinoma, Hepatocellular 1Bone Neoplasms 1

Interventions

Cisplatin 35Radiotherapy 20Magnetic Resonance Spectroscopy 19Cetuximab 17Specimen Handling 15pembrolizumab 13Carboplatin 13Radiotherapy, Intensity-Modulated 12Fluorouracil 12Docetaxel 121,2-diaminocyclohexaneplatinum II citrate 10Radiation 9Platinum 9Paclitaxel 8Surgical Procedures, Operative 7Drug Therapy 6Biopsy 6Taxes 5toripalimab 4X-Rays 4Standard of Care 4Fluorodeoxyglucose F18 4Celecoxib 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3Nutritional Status 3Laser Therapy 3Interviews as Topic 3Hydroxyurea 3130-nm albumin-bound paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Laryngeal Neoplasms × Cefazolin × Clear all
NCT00467948 2007-05-01

Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients

Tehran University of Medical Sciences

Phase 3 Completed
90 enrolled
Head & Neck

Laryngeal Neoplasms, Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡